IM Therapeutics Competitors and Similar CompaniesClear all

IM Therapeutics's competitors and similar companies include Viking Therapeutics, Apoglyx, Antag Therapeutics and Hua Medicine.

	IM Therapeutics IM Therapeutics is a company that develops personalized immuno-therapeutic drugs.	Viking Therapeutics Viking Therapeutics is a clinical-stage biotherapeutics company focused on the development of therapies for metabolic and endocrine disorders.	Apoglyx Apoglyx is a biotech company developing a small molecule oral therapy for type 2 diabetes patients.	Antag Therapeutics Antag Therapeutics is a preclinical-stage biotechnology company focused on developing therapies for dietary-related metabolic diseases.	Hua Medicine Hua Medicine (华领医药) is a drug development company.
Founding Date	Founding Date 2015	Founding Date 2012	Founding Date 2015	Founding Date 2017	Founding Date 2011
Type	Type Private	Type Public	Type Private	Type Subsidiary	Type Public
Tags	Tags Healthcare biotech diabetes drug development healthtech	Tags Healthcare biotech diabetes drug development	Tags Healthcare biotech diabetes drug development	Tags Healthcare biotech diabetes drug development pharma	Tags Healthcare biotech diabetes drug development pharma
Locations	Locations Woburn, US HQ Aurora, US	Locations San Diego, US HQ	Locations Malmö, SE HQ Lund, SE	Locations København, DK HQ	Locations Shanghai, CN HQ Beijing, CN Wuhan, CN Hong Kong, HK
Employees	Employees N/A	Employees 2729% increase	Employees 525% increase	Employees 20	Employees 168
Financial
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit N/A	Gross profit (kr13.1m) (FY, 2021)	Gross profit ¥1.6b (FY, 2025)
Net income	Net income N/A	Net income ($359.6m) (FY, 2025)	Net income N/A	Net income (kr14.9m) (FY, 2021)	Net income ¥1.1b (FY, 2025)
Funding
Total funding raised	Total funding raised $ 10m	Total funding raised $ 15m	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 242.4m